MedPath

3-dimensional Versus 2-dimensional Laparoscopy for Myomectomy

Not Applicable
Conditions
Laparoscopy
Registration Number
NCT04070716
Lead Sponsor
Kangbuk Samsung Hospital
Brief Summary

The aim of this study is to compare the surgical outcomes and efficacy of 3-dimensional (3D) versus 2-dimensional (2D) imaging systems in laparoscopic myomectomy..

Detailed Description

Laparoscopy is founded as a treatment of choice for benign uterine disease. The advantages of laparoscopic surgery over conventional open surgery are less pain, shorter recovery time, shorter hospital stay, and consequently faster return to normal activity as well as better cosmetic effects. However, laparoscopic surgery is more demanding compared with open surgery because operators should project three-dimensional (3D) field through a two-dimensional (2D) monitor.

However, to date, studies examining the possible benefits and drawbacks of 3D imaging system versus 2D in laparoscopic surgery have brought about conflicting results. Moreover, there have been few studies comparing the surgical outcomes of 3D and 2D laparoscopic laparoscopic myomectomy. The aim of this study is to compare the surgical outcomes and efficacy of 3-dimensional (3D) versus 2-dimensional (2D) imaging systems in laparoscopic myomectomy..

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
64
Inclusion Criteria
  • Uterine myoma requiring laparoscopic myomectomy
  • American Society of Anesthesiologists physical status (ASAPS) classification I-II
  • absence of pregnancy at the time of surgery.
Exclusion Criteria
  • any suspicious findings of malignant gynecologic diseases,

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Amount of operative blood lossAt the time of surgery

Amount of operative blood loss was measured by the anesthesiologists after defining it as the difference between the total amount of suction and irrigation plus the difference between the total gauze weight before and after surgery.

Secondary Outcome Measures
NameTimeMethod
Operative timeAt the day of surgery

Operative time was defined as the time from incision to closure of the skin.

Trial Locations

Locations (1)

Kangbuk Samsung Hospital

🇰🇷

Seoul, Korea, Republic of

Kangbuk Samsung Hospital
🇰🇷Seoul, Korea, Republic of
Taejong Song
Contact
1040358405
taejong.song@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.